Aclaris Therapeutics
ACRS
ACRS
96 hedge funds and large institutions have $130M invested in Aclaris Therapeutics in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 30 increasing their positions, 28 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 36
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
96
Holding in Top 10
1
Calls
$5K
Puts
–
Top Buyers
| 1 | +$5.9M | |
| 2 | +$2.4M | |
| 3 | +$1.82M | |
| 4 |
Morgan Stanley
New York
|
+$1.6M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$872K |
Top Sellers
| 1 | -$7.14M | |
| 2 | -$1.79M | |
| 3 | -$1.36M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$1.19M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$706K |
